InvestorsHub Logo
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

Re: Double_Bagel post# 16208

Friday, 12/02/2016 4:18:37 PM

Friday, December 02, 2016 4:18:37 PM

Post# of 20689

TEVA is down from $70 to $36. It is crazy that the market thinks Teva is going to lose all of its Copaxone sales (if not, why has the stock been cut in half) and yet thinks MNTA / NVS will sell none of the 40 mg Copaxone.

Not all of TEVA's sell-off is attributable to Copaxone. Other issues for TEVA are: i) overpaying for AGN's generic-drug business; and ii) negative year-over-year price growth for US generic drugs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”